KISQALI vs PHYRAGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. KISQALI and PHYRAGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KISQALI	PHYRAGO
Rating	70/100	New
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	RIBOCICLIB SUCCINATE	DASATINIB
Manufacturer	Novartis	Handa Therap
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Breast Neoplasms	Lymphoid Leukemia, Myeloid Leukemia

kisqali phyrago

Rating

70/100

New

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

RIBOCICLIB SUCCINATE

DASATINIB

Manufacturer

Novartis

Handa Therap

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Breast Neoplasms

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

What is the difference between Kisqali and Phyrago?

Kisqali contains Ribociclib Succinate, while Phyrago contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.